MESA LABORATORIES INC CO
For the period ended Jun 30, 2024. Filed Aug 5, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 5, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
The following of our directors or officers entered into written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Exchange Act Rule10b5-1(c) (each, a "trading arrangement") on the dates indicated:
Senior Vice President of Continuous Improvement Brian Archbold entered into a trading arrangement on* June 12, 2024.The trading arrangement is effective through May 30, 2025,and contemplates that Mr. Archbold may*sell 558 shares of Mesa Labs' common stock, subject to certain conditions.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.